Pacific Biosciences Of California Cash on Hand 2010-2024 | PACB

Pacific Biosciences Of California cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Pacific Biosciences Of California Annual Cash on Hand
(Millions of US $)
2023 $632
2022 $773
2021 $1,045
2020 $320
2019 $49
2018 $102
2017 $63
2016 $72
2015 $82
2014 $101
2013 $113
2012 $101
2011 $177
2010 $284
2009 $93
Pacific Biosciences Of California Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $562
2023-12-31 $632
2023-09-30 $768
2023-06-30 $830
2023-03-31 $875
2022-12-31 $773
2022-09-30 $835
2022-06-30 $899
2022-03-31 $963
2021-12-31 $1,045
2021-09-30 $1,080
2021-06-30 $1,145
2021-03-31 $1,161
2020-12-31 $320
2020-09-30 $209
2020-06-30 $120
2020-03-31 $143
2019-12-31 $49
2019-09-30 $49
2019-06-30 $67
2019-03-31 $83
2018-12-31 $102
2018-09-30 $116
2018-06-30 $63
2018-03-31 $79
2017-12-31 $63
2017-09-30 $84
2017-06-30 $103
2017-03-31 $56
2016-12-31 $72
2016-09-30 $87
2016-06-30 $102
2016-03-31 $92
2015-12-31 $82
2015-09-30 $59
2015-06-30 $73
2015-03-31 $79
2014-12-31 $101
2014-09-30 $99
2014-06-30 $105
2014-03-31 $119
2013-12-31 $113
2013-09-30 $127
2013-06-30 $107
2013-03-31 $112
2012-12-31 $101
2012-09-30 $119
2012-06-30 $137
2012-03-31 $161
2011-12-31 $177
2011-09-30 $194
2011-06-30 $217
2011-03-31 $249
2010-12-31 $284
2010-09-30 $113
2010-06-30
2010-03-31
2009-12-31
2009-09-30
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.490B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $208.577B 25.27
Intuitive Surgical (ISRG) United States $163.861B 92.78
Edwards Lifesciences (EW) United States $53.023B 34.51
Alcon (ALC) Switzerland $44.787B 32.08
IQVIA Holdings (IQV) United States $44.681B 25.33
DexCom (DXCM) United States $44.401B 67.26
IDEXX Laboratories (IDXX) United States $39.253B 46.01
STERIS (STE) Ireland $22.615B 26.42
Hologic (HOLX) United States $18.292B 20.47
Waters (WAT) United States $18.224B 26.78
SONOVA HOLDING (SONVY) Switzerland $17.878B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $11.502B 13.43
Teleflex (TFX) United States $10.485B 16.32
Sysmex ADR (SSMXY) Japan $10.241B 32.12
Globus Medical (GMED) United States $9.940B 29.14
Penumbra (PEN) United States $7.453B 84.69
Glaukos (GKOS) United States $6.184B 0.00
Masimo (MASI) United States $5.714B 32.86
TransMedics (TMDX) United States $4.913B 466.16
Integer Holdings (ITGR) United States $4.328B 26.15
PROCEPT BioRobotics (PRCT) United States $3.553B 0.00
Inari Medical (NARI) United States $3.210B 0.00
LivaNova (LIVN) United Kingdom $2.938B 17.45
Tandem Diabetes Care (TNDM) United States $2.792B 0.00
Integra LifeSciences Holdings (IART) United States $2.485B 10.84
Veracyte (VCYT) United States $1.794B 0.00
RxSight (RXST) United States $1.754B 0.00
Alphatec Holdings (ATEC) United States $1.525B 0.00
Artivion (AORT) United States $1.146B 109.88
Silk Road Medical (SILK) United States $1.067B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.033B 20.10
Pulse Biosciences (PLSE) United States $1.030B 0.00
OPKO Health (OPK) United States $1.018B 0.00
OrthoPediatrics (KIDS) United States $0.789B 0.00
SiBone (SIBN) United States $0.693B 0.00
Paragon 28 (FNA) United States $0.672B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.602B 0.00
Mesa Laboratories (MLAB) United States $0.599B 17.73
IRadimed (IRMD) United States $0.584B 32.68
Treace Medical Concepts (TMCI) United States $0.493B 0.00
AxoGen (AXGN) United States $0.404B 0.00
Sight Sciences (SGHT) United States $0.397B 0.00
Nevro (NVRO) United States $0.349B 0.00
Tactile Systems Technology (TCMD) United States $0.301B 10.31
AngioDynamics (ANGO) United States $0.286B 0.00
Semler Scientific (SMLR) United States $0.242B 12.28
Delcath Systems (DCTH) United States $0.231B 0.00
NeuroPace (NPCE) United States $0.220B 0.00
Inogen (INGN) United States $0.217B 0.00
CVRx (CVRX) United States $0.212B 0.00
ClearPoint Neuro (CLPT) United States $0.198B 0.00
Accuray (ARAY) United States $0.194B 0.00
908 Devices (MASS) United States $0.191B 0.00
Atossa Genetics (ATOS) United States $0.186B 0.00
EDAP TMS S.A (EDAP) France $0.184B 0.00
Alpha Tau Medical (DRTS) Israel $0.144B 0.00
KORU Medical Systems (KRMD) United States $0.120B 0.00
Spectral Diagnostics (EDTXF) Canada $0.106B 0.00
Sensus Healthcare (SRTS) United States $0.106B 22.24
Hyperfine (HYPR) United States $0.085B 0.00
EnVVeno Medical (NVNO) United States $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.072B 0.00
LENSAR (LNSR) United States $0.060B 0.00
InspireMD (NSPR) Israel $0.060B 0.00
Neuronetics (STIM) United States $0.057B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Vicarious Surgical (RBOT) United States $0.044B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Rapid Micro Biosystems (RPID) United States $0.030B 0.00
Autonomix Medical (AMIX) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.026B 0.00
Ekso Bionics Holdings (EKSO) United States $0.023B 0.00
Aspira Women's Health (AWH) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.021B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
NexGel (NXGL) United States $0.015B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00